Detail of outcome
The key conclusion of the triennial (3 yearly) review was that the CHM performs necessary functions and should continue to operate as an advisory non-departmental public body. The review report also contains recommendations to improve performance, governance, and efficiency.
This consultation ran from to
Seeks views on the role and performance of the Commission on Human Medicines (CHM)
The department reviews its arm’s length bodies once every 3 years.
This triennial (3 yearly) review looks at what the CHM does and how.
We want to know what you think of the CHM, including:
- whether the CHM needs to continue in its current form
- how the CHM is performing
- whether the CHM is providing good value